Back to News & Events

Investigations into Tissue Distribution and Inhibition of Food Consumption with Efpeglenatide

Share this

About this Poster:

Efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist in development for type 2 diabetes, induces weight loss through satiety and reduced food intake. Studies in Sprague Dawley rats investigated how peripheral and central mechanisms contribute to the anorectic effects of efpeglenatide.

Your development journey
starts with a conversation.

ProSciento
Privacy Overview

More information about our Privacy Policy can be found here.